TG Therapeutics | TGTX - Trade Debtors



TG Therapeutics reported $231.52M in Trade Debtors for its fiscal quarter ending in June of 2025.


Trade Debtors Change Date
AbbVie USD 12.48B 1.56B Mar/2025
Alaunos Therapeutics USD 5K 5K Dec/2024
Amgen USD 8.7B 569M Jun/2025
Ardelyx USD 62.55M 4.84M Jun/2025
Arrowhead Research USD 9.7M 7.33M Jun/2025
Bayer EUR 17.64B 895M Jun/2025
Biogen USD 2.08B 87.5M Jun/2025
Corcept Therapeutics USD 64.57M 2.75M Jun/2025
Dynavax Technologies USD 73.34M 16.79M Jun/2025
Gilead Sciences USD 4.78B 393M Jun/2025
J&J USD 16.02B 1.18B Mar/2025
Novartis USD 9.18B 451M Jun/2025
PTC Therapeutics USD 196.13M 14.36M Jun/2025
Regeneron Pharmaceuticals USD 5.61B 49M Jun/2025
Roche Holding CHF 13.46B 984M Dec/2024
TG Therapeutics USD 231.52M 102.33M Jun/2025
Vertex Pharmaceuticals USD 1.89B 88.4M Jun/2025